United Therapeutics (UTHR)
(Real Time Quote from BATS)
$339.47 USD
+7.88 (2.38%)
Updated Jul 25, 2024 09:51 AM ET
2-Buy of 5 2
B Value A Growth C Momentum A VGM
Earnings News For UTHR
-
Why Is United Therapeutics (UTHR) Up 4.8% Since Last Earnings Report?
-
United Therapeutics (UTHR) Q1 Earnings Top, Tyvaso Drives Sales
-
United Therapeutics: Q1 Earnings Snapshot
-
United Therapeutics Corporation Reports First Quarter 2024 Financial Results
-
United Therapeutics (UTHR) Earnings Expected to Grow: Should You Buy?
-
Why Is United Therapeutics (UTHR) Up 8.9% Since Last Earnings Report?
-
United Therapeutics (UTHR) Q4 Earnings & Sales Beat Estimates
-
United Therapeutics: Q4 Earnings Snapshot
-
United Therapeutics Corporation Reports Fourth Quarter and Full Year 2023 Financial Results
-
United Therapeutics (UTHR) Up 5.2% Since Last Earnings Report: Can It Continue?
-
United Therapeutics (UTHR) Q3 Earnings & Sales Beat Estimates
-
United Therapeutics (UTHR) Q3 Earnings and Revenues Top Estimates
-
United Therapeutics: Q3 Earnings Snapshot
-
United Therapeutics Corporation Reports Third Quarter 2023 Financial Results
-
Analysts Estimate United Therapeutics (UTHR) to Report a Decline in Earnings: What to Look Out for
-
United Therapeutics (UTHR) Q2 Earnings & Sales Beat Estimates
-
United Therapeutics (UTHR) Tops Q2 Earnings and Revenue Estimates
-
United Therapeutics: Q2 Earnings Snapshot
-
United Therapeutics Corporation Reports Second Quarter 2023 Financial Results
-
United Therapeutics (UTHR) Earnings Expected to Grow: What to Know Ahead of Q2 Release
-
United Therapeutics (UTHR) Q1 Earnings Beat, Sales Miss
-
United Therapeutics (UTHR) Q1 Earnings Beat Estimates
-
United Therapeutics: Q1 Earnings Snapshot
-
United Therapeutics Corporation Reports First Quarter 2023 Financial Results
-
Earnings Preview: United Therapeutics (UTHR) Q1 Earnings Expected to Decline